Report Detail

Healthcare North America Contrast and Imaging Agents in Interventional X-ray Market Industry Trends Forecast to 2026

  • RnM2921951
  • |
  • 11 February, 2019
  • |
  • Global
  • |
  • 100 Pages
  • |
  • Data Bridge Market Research
  • |
  • Healthcare

North America contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.3% in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Agent Type (Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Gold Nanoparticle Contrast Agents, Others), Application (Cardiology, Gastroenterology, Neurology, Oncology, Urology, General Surgery), End User (Imaging Centers, Hospital, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Private Practices), Country (U.S., Canada and Mexico)

Major growing sectors under the market segmentation are as follows:

• In agent type, iodinated contrast media is dominating as well as the fastest growing segment in this market.
• In application, cardiology is dominating as well as the fastest growing segment in this market.
• In end user, imaging centers is dominating as well as the fastest growing segment in this market.

Market Players

The key market players for North America contrast and imaging agents in interventional X-ray market are listed below:

• General Electric Company
• BRACCO
• Guerbet
• Lantheus Medical Imaging, Inc.
• FUJIFILM VisualSonics Inc.
• Jodas Expoim
• TAEJOON PHARM
• Unijules Life Sciences Ltd.
• J.B.Chemicals & Pharmaceuticals Ltd.
• iMAX
• Novalek Pharmaceuticals Pvt. Ltd.
• Nano Therapeutics Pvt Ltd
• Others


TABLE OF CONTENTS

    1 INTRODUCTION

    • 1.1 OBJECTIVES OF THE STUDY
    • 1.2 MARKET DEFINITION
    • 1.3 OVERVIEW OF NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET
    • 1.4 CURRENCY AND PRICING
    • 1.5 LIMITATION
    • 1.6 MARKETS COVERED

    2 MARKET SEGMENTATION

    • 2.1 MARKETS COVERED
    • 2.2 GEOGRAPHIC SCOPE
    • 2.3 YEARS CONSIDERED FOR THE STUDY
    • 2.4 CURRENCY AND PRICING
    • 2.5 RESEARCH METHODOLOGY
    • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
    • 2.7 DBMR MARKET CHALLENGE MATRIX
    • 2.8 MARKET APPLICATION COVERAGE GRID
    • 2.9 DBMR VENDOR SHARE ANALYSIS
    • 2.10 SECONDARY SOURCES
    • 2.11 ASSUMPTIONS

    3 MARKET OVERVIEW

    • 3.1 DRIVERS
      • 3.1.1 RISING NUMBER OF CHRONIC DISEASES
      • 3.1.2 RISING AGING POPULATION
      • 3.1.3 GROWING NUMBER OF DIAGNOSTIC CENTERS
      • 3.1.4 INCREASE IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES OF CONTRAST AGENTS
    • 3.2 RESTRAINT
      • 3.2.1 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS
    • 3.3 OPPORTUNITIES
      • 3.3.1 RISING HEALTHCARE EXPENDITURE
      • 3.3.2 INCREASE IN NUMBER OF PUBLIC AND PRIVATE HOSPITALS
    • 3.4 CHALLENGE
      • 3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT

    4 EXECUTIVE SUMMARY

      5 PREMIUM INSIGHTS

        6 KEY PRIMARY INSIGHTS

          7 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE

          • 7.1 OVERVIEW
          • 7.2 IODINATED CONTRAST MEDIA
          • 7.3 BARIUM-BASED CONTRAST MEDIA
          • 7.4 MICROBUBBLE CONTRAST MEDIA
          • 7.5 GOLD NANOPARTICLE CONTRAST AGENTS
          • 7.6 OTHERS

          8 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION

          • 8.1 OVERVIEW
          • 8.2 CARDIOLOGY
            • 8.2.1 PERCUTANEOUS CORONARY INTERVENTION
            • 8.2.2 STRUCTURAL HEART DISEASE
            • 8.2.3 CONGENITAL HEART DISEASE
            • 8.2.4 ELECTROPHYSIOLOGY
          • 8.3 GASTROENTEROLOGY
          • 8.4 NEUROLOGY
          • 8.5 ONCOLOGY
          • 8.6 UROLOGY
          • 8.7 GENERAL SURGERY

          9 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER

          • 9.1 OVERVIEW
          • 9.2 IMAGING CENTERS
          • 9.3 HOSPITAL
          • 9.4 CLINICS
          • 9.5 DIAGNOSTIC CENTER
          • 9.6 AMBULATORY SURGICAL CENTERS
          • 9.7 PRIVATE PRACTICES

          10 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY

          • 10.1 NORTH AMERICA
            • 10.1.1 U.S.
            • 10.1.2 CANADA
            • 10.1.3 MEXICO

          11 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE

          • 11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

          12 COMPANY PROFILES

          • 12.1 BRACCO
            • 12.1.1 COMPANY SNAPSHOT
            • 12.1.2 GEOGRAPHICAL PRESENCE
            • 12.1.3 COMPANY SHARE ANALYSIS
            • 12.1.4 PRODUCT PORTFOLIO
            • 12.1.5 RECENT DEVELOPMENTS
          • 12.2 GENERAL ELECTRIC COMPANY
            • 12.2.1 COMPANY SNAPSHOT
            • 12.2.2 REVENEUE ANALYSIS
            • 12.2.3 COMPANY SHARE ANALYSIS
            • 12.2.4 PRODUCT PORTFOLIO
            • 12.2.5 RECENT DEVELOPMENTS
          • 12.3 GUERBET
            • 12.3.1 COMPANY SNAPSHOT
            • 12.3.2 REVENEUE ANALYSIS
            • 12.3.3 COMPANY SHARE ANALYSIS
            • 12.3.4 PRODUCT PORTFOLIO
            • 12.3.5 RECENT DEVELOPMENTS
          • 12.4 FUJIFILM VISUALSONICS INC.
            • 12.4.1 COMPANY SNAPSHOT
            • 12.4.2 GEOGRAPHICAL PRESENCE
            • 12.4.3 PRODUCT PORTFOLIO
            • 12.4.4 RECENT DEVELOPMENT
          • 12.5 IMAX
            • 12.5.1 COMPANY SNAPSHOT
            • 12.5.2 GEOGRAPHICAL PRESENCE
            • 12.5.3 PRODUCT PORTFOLIO
            • 12.5.4 RECENT DEVELOPMENT
          • 12.6 J.B. CHEMICALS & PHARMACEUTICALS LTD.
            • 12.6.1 COMPANY SNAPSHOT
            • 12.6.2 REVENUE ANALYSIS
            • 12.6.3 PRODUCT PORTFOLIO
            • 12.6.4 RECENT DEVELOPMENT
          • 12.7 JODAS EXPOIM
            • 12.7.1 COMPANY SNAPSHOT
            • 12.7.2 GEOGRAPHICAL PRESENCE
            • 12.7.3 PRODUCT PORTFOLIO
            • 12.7.4 RECENT DEVELOPMENTS
          • 12.8 LANTHEUS MEDICAL IMAGING, INC.
            • 12.8.1 COMPANY SNAPSHOT
            • 12.8.2 REVENUE ANALYSIS
            • 12.8.3 PRODUCT PORTFOLIO
            • 12.8.4 RECENT DEVELOPMENTS
          • 12.9 NANO THERAPEUTICS PVT. LTD.
            • 12.9.1 COMPANY SNAPSHOT
            • 12.9.2 GEOGRAPHICAL PRESENCE
            • 12.9.3 PRODUCT PORTFOLIO
            • 12.9.4 RECENT DEVELOPMENT
          • 12.10 NOVALEK PHARMACEUTICALS PVT. LTD.
            • 12.10.1 COMPANY SNAPSHOT
            • 12.10.2 GEOGRAPHICAL PRESENCE
            • 12.10.3 PRODUCT PORTFOLIO
            • 12.10.4 RECENT DEVELOPMENT
          • 12.11 TAEJOON PHARM
            • 12.11.1 COMPANY SNAPSHOT
            • 12.11.2 GEOGRAPHICAL PRESENCE
            • 12.11.3 PRODUCT PORTFOLIO
            • 12.11.4 RECENT DEVELOPMENT
          • 12.12 UNIJULES LIFE SCIENCES LTD.
            • 12.12.1 COMPANY SNAPSHOT
            • 12.12.2 PRODUCT PORTFOLIO
            • 12.12.3 RECENT DEVELOPMENT

          13 QUESTIONNAIRE

            14 RELATED REPORTS

            Summary:
            Get latest Market Research Reports on North America Contrast and Imaging Agents in Interventional X-ray . Industry analysis & Market Report on North America Contrast and Imaging Agents in Interventional X-ray is a syndicated market report, published as North America Contrast and Imaging Agents in Interventional X-ray Market Industry Trends Forecast to 2026. It is complete Research Study and Industry Analysis of North America Contrast and Imaging Agents in Interventional X-ray market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

            Last updated on

            REPORT YOU MIGHT BE INTERESTED

            Purchase this Report

            $2,500.00
            $3,200.00
            1,980.00
            2,534.40
            2,310.00
            2,956.80
            378,225.00
            484,128.00
            208,425.00
            266,784.00
            Credit card Logo

            Related Reports


            Reason to Buy

            Request for Sample of this report